Boomerang Portfolio Company Closes Add-On Acquisition, Expanding the Platform's Market Reach & Capabilities for Health Systems Across the Country NASHVILLE, Tenn., Dec. 16, 2025 /PRNewswire/ -- Enjoin ...

Value physician expertise revenue drives better clinical documentation and boosts financial performance in health systems like Emory and Texas Health.

Omeros’ Yartemlea gets US FDA approval to treat hematopoietic stem cell transplant-associated thrombotic microangiopathy: Seattle Monday, December 29, 2025, 12:00 Hrs [IST] Omer ...

Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...

Background Amyloid transthyretin (ATTR) amyloidosis is a rare, life-threatening disease frequently manifesting with ...

What does American Home Shield cover in 2026? This American Home Shield review covers cost, plans, coverage and what you need ...

Seborrheic dermatitis is associated with other epithelial barrier diseases of the skin and beyond, including the respiratory, ...

All hospitals nationwide have been placed under Code White until Jan. 6, 2025, as the Department of Health (DOH) braces for a possible increase in ...

A research team from Scotland, England and Germany analysed data comparing outcomes for patients when an MSU responded to a ...

Diagnosed with Alzheimer’s in her late 30s, Sandra Demontigny pushed Quebec to allow advanced requests for MAID. While Quebec has become a leader internationally for the practice over the past decade, ...

As COVID completes its sixth year, official statistics obscure the scale of harm, while Long COVID and excess deaths reveal ...

Originally classified as ‘junk DNA’, genomic regions which are transcribed into RNAs that do not serve as template for protein production have attracted increasing attention in the last two decades.